IHC has been utilized to distinguish the expression through the phenotype of breast cancer cell lines with tyrosine kinase receptors such as HER2 and the Epidermal Growth Factor receptor (EGFR) [21]. This evidence concerns the gene NTRK1 and breast carcinoma.